Market Cap

Medacta Group SA Market Capitalization:

CHF3.12 Billion

CHF as of Jan. 1, 2026

US$3.93 Billion

business Medacta Group SA Company Profile

Medacta Group SA Main Stock Listing

SIX: MOVE

Market Capitalization History of Medacta Group SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $216.15 B
Boston Scientific Corporation $140.40 B
Stryker $133.15 B
Medtronic $123.20 B
Edwards Lifesciences Corporation $50.10 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Medacta Group SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 CHF3.12 B 46.94%
Jan. 1, 2025 CHF2.12 B -13.10%
Jan. 1, 2024 CHF2.44 B 17.79%
Jan. 1, 2023 CHF2.07 B -10.47%
Jan. 1, 2022 CHF2.32 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Medacta Group SA Categories

Switzerland languages Healthcare languages Medical Devices
Switzerland Healthcare Switzerland Medical Devices

Stocks & Indices

Medacta Group SA has the following listings and related stock indices.


Stock: SIX: MOVE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.